FDA approves Lexicon Pharma's carcinoid syndrome diarrhea drug
(Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved Lexicon Pharmaceuticals Inc's oral drug to treat carcinoid syndrome diarrhea, a condition that develops in patients with gastrointestinal tumors.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Cancer & Oncology | Carcinoid Tumor | Food and Drug Administration (FDA) | Gastroenterology | Health | Pharmaceuticals